Your browser doesn't support javascript.
loading
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.
Grannan, Michael D; Mielnik, Catharine A; Moran, Sean P; Gould, Robert W; Ball, Jacob; Lu, Zhuoyan; Bubser, Michael; Ramsey, Amy J; Abe, Masahito; Cho, Hyekyung P; Nance, Kellie D; Blobaum, Anna L; Niswender, Colleen M; Conn, P Jeffrey; Lindsley, Craig W; Jones, Carrie K.
Affiliation
  • Grannan MD; Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Mielnik CA; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Moran SP; Department of Pharmacology and Toxicology, University of Toronto , Toronto, Ontario M5S 1A8, Canada.
  • Gould RW; Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Ball J; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Lu Z; Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Bubser M; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Ramsey AJ; Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Abe M; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Cho HP; Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Nance KD; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Blobaum AL; Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Niswender CM; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Conn PJ; Department of Pharmacology and Toxicology, University of Toronto , Toronto, Ontario M5S 1A8, Canada.
  • Lindsley CW; Department of Pharmacology, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
  • Jones CK; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center , Nashville, Tennessee 37232, United States.
ACS Chem Neurosci ; 7(12): 1706-1716, 2016 12 21.
Article in En | MEDLINE | ID: mdl-27617634

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prefrontal Cortex / Receptors, N-Methyl-D-Aspartate / Nootropic Agents / Cholinergic Agents / Heterocyclic Compounds, 4 or More Rings / Nerve Tissue Proteins Type of study: Prognostic_studies Limits: Animals Language: En Journal: ACS Chem Neurosci Year: 2016 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prefrontal Cortex / Receptors, N-Methyl-D-Aspartate / Nootropic Agents / Cholinergic Agents / Heterocyclic Compounds, 4 or More Rings / Nerve Tissue Proteins Type of study: Prognostic_studies Limits: Animals Language: En Journal: ACS Chem Neurosci Year: 2016 Type: Article Affiliation country: United States